Ulla Feldt-Rasmussen

Ulla Feldt-Rasmussen

Clinical Professor


  1. 2018
  2. Published

    Safety and convenience of once-weekly somapacitan in adult GH deficiency: A 26-week randomized, controlled trial

    Johannsson, G., Feldt-Rasmussen, Ulla, Håkonsson, I. H., Biering, H., Rodien, P., Tahara, S., Toogood, A. & Rasmussen, M. H., 2018, In: European Journal of Endocrinology. 178, 5, p. 491-499 9 p.

    Research output: Contribution to journalJournal articlepeer-review

  3. Published

    Semen quality in patients with pituitary disease and adult-onset hypogonadotropic hypogonadism

    Andreassen, Mikkel, Juul, Anders, Feldt-Rasmussen, Ulla & Jørgensen, N., 2018, In: Endocrine Connections. 7, 4, p. 523-533 11 p.

    Research output: Contribution to journalJournal articlepeer-review

  4. Published

    Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: A randomized multicentre study

    Dal, J., Klose, M., Heck, A., Andersen, M., Kistorp, Caroline Michaela Nervil, Nielsen, E. H., Bollerslev, J., Feldt-Rasmussen, Ulla & Jørgensen, J. O. L., 2018, In: European Journal of Endocrinology. 178, 1, p. 65-74 10 p.

    Research output: Contribution to journalJournal articlepeer-review

  5. Published

    ThyPROgr: the Greek edition of the ThyPRO questionnaires for patients with benign thyroid diseases

    Mintziori, G., Watt, T., Veneti, S., Panagiotou, A., Pournaras, D. J., Feldt-Rasmussen, Ulla, Rasmussen, Å. K., Hegedus, L., Bonnema, S. J., Bjørner, Jakob Bue, Kita, M. & Goulis, D. G., 2018, In: Hormones. 17, 1, p. 107-112 6 p.

    Research output: Contribution to journalJournal articlepeer-review

  6. Published

    Thyroid Function and Depression

    Jørgensen, Martin Balslev & Feldt-Rasmussen, Ulla, 2018, Encyclopedia of Endocrine Diseases. 2 ed. Elsevier, Vol. 4. p. 792-801

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  7. Published

    Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

    Bengtsson, D., Schrøder, H. D., Berinder, K., Maiter, D., Hoybye, C., Ragnarsson, O., Feldt-Rasmussen, Ulla, Krogh Rasmussen, R., van der Lely, A., Petersson, M., Johannsson, G., Andersen, M. & Burman, P., 2018, In: Endocrine. 62, 3, p. 737-739 3 p.

    Research output: Contribution to journalLetterpeer-review

Previous 1 2 3 4 Next

ID: 916030